Vanguard Personalized Indexing Management
CCCC icon

Vanguard Personalized Indexing Management’s C4 Therapeutics CCCC Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.4K Sell
14,425
-824
-5% -$2.82K ﹤0.01% 2106
2026
Q1 		$40.1K Buy
15,249
+25
+0.2% +$59 ﹤0.01% 2077
2025
Q4 		$29.1K Buy
15,224
+650
+4% +$1.54K ﹤0.01% 1921
2025
Q3 		$32.4K Sell
14,574
-146
-1% -$350 ﹤0.01% 1947
2025
Q2 		$21.1K Sell
14,720
-4,875
-25% -$7.09K ﹤0.01% 1903
2025
Q1 		$31.4K Buy
+19,595
New +$58.4K ﹤0.01% 1721

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Personalized Indexing Management's CCCC Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its C4 Therapeutics (CCCC) stake by 5.4% in Q2 2026, selling an estimated $2.82K and leaving 14,425 shares worth $67.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2106.

Vanguard Personalized Indexing Management first reported a position in CCCC in Q1 2025 and has held it in 6 quarters since. 148 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • Vanguard Personalized Indexing Management held 14,425 shares of C4 Therapeutics worth $67.4K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 824 C4 Therapeutics shares in Q2 2026, an estimated $2.82K.
  • C4 Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2106 holding.
  • Vanguard Personalized Indexing Management first reported a position in C4 Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 148 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.